
| (Commission File Number) | (IRS Employer Identification No.) | |||||||
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 7.01. | Regulation FD Disclosure. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| Exhibit Number | Exhibit Description | Filed Herewith | ||||||
| 99.1 | X | |||||||
| 99.2 | X | |||||||
| 99.3 | X | |||||||
| 104 | Cover page interactive data file - The cover page from this Current Report on Form 8-K is formatted as Inline XBRL | X | ||||||
| TRUEBLUE, INC. | ||||||||||||||
| (Registrant) | ||||||||||||||
| Date: | February 19, 2025 | By: | /s/ Carl R. Schweihs | |||||||||||
Carl R. Schweihs | ||||||||||||||
Chief Financial Officer and Executive Vice President | ||||||||||||||
| Q4 2024 | Q4 2023 | 2024 | 2023 | ||||||||||||||||||||
13 weeks ended | 14 weeks ended (1) | 52 weeks ended | 53 weeks ended (1) | ||||||||||||||||||||
| (in thousands, except per share data) | Dec 29, 2024 | Dec 31, 2023 | Dec 29, 2024 | Dec 31, 2023 | |||||||||||||||||||
| Revenue from services | $ | 385,953 | $ | 492,171 | $ | 1,567,393 | $ | 1,906,243 | |||||||||||||||
| Cost of services | 283,406 | 363,889 | 1,161,000 | 1,400,184 | |||||||||||||||||||
| Gross profit | 102,547 | 128,282 | 406,393 | 506,059 | |||||||||||||||||||
| Selling, general and administrative expense | 106,942 | 129,961 | 410,870 | 494,603 | |||||||||||||||||||
| Depreciation and amortization | 6,008 | 6,946 | 28,624 | 25,821 | |||||||||||||||||||
| Goodwill and intangible asset impairment charge | — | — | 59,674 | 9,485 | |||||||||||||||||||
| Loss from operations | (10,403) | (8,625) | (92,775) | (23,850) | |||||||||||||||||||
Interest and other income (expense), net | 390 | 1,223 | 4,251 | 3,205 | |||||||||||||||||||
Loss before tax expense (benefit) | (10,013) | (7,402) | (88,524) | (20,645) | |||||||||||||||||||
| Income tax expense (benefit) | 1,692 | (4,851) | 37,224 | (6,472) | |||||||||||||||||||
| Net loss | $ | (11,705) | $ | (2,551) | $ | (125,748) | $ | (14,173) | |||||||||||||||
| Net loss per common share: | |||||||||||||||||||||||
| Basic | $ | (0.40) | $ | (0.08) | $ | (4.17) | $ | (0.45) | |||||||||||||||
| Diluted | $ | (0.40) | $ | (0.08) | $ | (4.17) | $ | (0.45) | |||||||||||||||
| Weighted average shares outstanding: | |||||||||||||||||||||||
| Basic | 29,561 | 31,079 | 30,177 | 31,317 | |||||||||||||||||||
| Diluted | 29,561 | 31,079 | 30,177 | 31,317 | |||||||||||||||||||
| (in thousands) | Dec 29, 2024 | Dec 31, 2023 | |||||||||
| ASSETS | |||||||||||
| Cash and cash equivalents | $ | 22,536 | $ | 61,885 | |||||||
| Accounts receivable, net | 214,704 | 252,538 | |||||||||
| Other current assets | 39,853 | 40,570 | |||||||||
| Total current assets | 277,093 | 354,993 | |||||||||
| Property and equipment, net | 89,602 | 104,906 | |||||||||
Restricted cash, cash equivalents and investments | 179,916 | 192,985 | |||||||||
| Goodwill and intangible assets, net | 30,406 | 94,639 | |||||||||
| Other assets, net | 98,359 | 151,860 | |||||||||
| Total assets | $ | 675,376 | $ | 899,383 | |||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||
| Accounts payable and other accrued expenses | $ | 45,599 | $ | 56,401 | |||||||
| Accrued wages and benefits | 61,380 | 80,120 | |||||||||
| Current portion of workers’ compensation claims reserve | 34,729 | 44,866 | |||||||||
| Other current liabilities | 18,417 | 22,712 | |||||||||
| Total current liabilities | 160,125 | 204,099 | |||||||||
| Workers’ compensation claims reserve, less current portion | 105,063 | 151,649 | |||||||||
| Long-term debt, less current portion | 7,600 | — | |||||||||
| Other long-term liabilities | 87,229 | 85,762 | |||||||||
| Total liabilities | 360,017 | 441,510 | |||||||||
| Shareholders’ equity | 315,359 | 457,873 | |||||||||
| Total liabilities and shareholders’ equity | $ | 675,376 | $ | 899,383 | |||||||
52 weeks ended | 53 weeks ended (1) | ||||||||||
| (in thousands) | Dec 29, 2024 | Dec 31, 2023 | |||||||||
| Cash flows from operating activities: | |||||||||||
| Net loss | $ | (125,748) | $ | (14,173) | |||||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||||||
Depreciation and amortization (inclusive of depreciation included in cost of services) | 29,561 | 25,821 | |||||||||
| Goodwill and intangible asset impairment charge | 59,674 | 9,485 | |||||||||
| Provision for credit losses | 2,321 | 4,972 | |||||||||
| Stock-based compensation | 7,591 | 13,907 | |||||||||
| Deferred income taxes | 34,060 | (9,902) | |||||||||
| Non-cash lease expense | 12,402 | 12,591 | |||||||||
| Other operating activities | (5,137) | (3,831) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | 35,731 | 56,761 | |||||||||
| Income taxes receivable and payable | 3,196 | (1,317) | |||||||||
| Other assets | 22,766 | 31,366 | |||||||||
| Accounts payable and other accrued expenses | (8,908) | (19,210) | |||||||||
| Accrued wages and benefits | (19,147) | (12,113) | |||||||||
| Workers’ compensation claims reserve | (56,723) | (54,495) | |||||||||
| Operating lease liabilities | (12,324) | (12,796) | |||||||||
| Other liabilities | 3,627 | 7,688 | |||||||||
| Net cash (used in) provided by operating activities | (17,058) | 34,754 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Capital expenditures | (24,151) | (31,276) | |||||||||
| Proceeds from business divestiture, net | 3,099 | — | |||||||||
| Payments for company-owned life insurance | (4,000) | (2,347) | |||||||||
| Proceeds from company-owned life insurance | — | 1,662 | |||||||||
| Purchases of restricted held-to-maturity investments | (11,242) | (34,110) | |||||||||
| Maturities of restricted held-to-maturity investments | 33,841 | 33,749 | |||||||||
| Net cash used in investing activities | (2,453) | (32,322) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Purchases and retirement of common stock | (21,293) | (34,178) | |||||||||
| Net proceeds from employee stock purchase plans | 738 | 856 | |||||||||
| Common stock repurchases for taxes upon vesting of restricted stock | (2,325) | (4,161) | |||||||||
| Net change in revolving credit facility | 7,600 | — | |||||||||
| Other | (1,807) | (100) | |||||||||
| Net cash used in financing activities | (17,087) | (37,583) | |||||||||
| Change in cash, cash equivalents and restricted cash reclassified to assets held-for-sale | — | (300) | |||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents | (1,608) | (874) | |||||||||
| Net change in cash, cash equivalents, and restricted cash and cash equivalents | (38,206) | (36,325) | |||||||||
| Cash, cash equivalents and restricted cash and cash equivalents, beginning of period | 99,306 | 135,631 | |||||||||
| Cash, cash equivalents and restricted cash and cash equivalents, end of period | $ | 61,100 | $ | 99,306 | |||||||
| Q4 2024 | Q4 2023 | 2024 | 2023 | ||||||||||||||||||||
13 weeks ended | 14 weeks ended (1) | 52 weeks ended | 53 weeks ended (1) | ||||||||||||||||||||
| (in thousands) | Dec 29, 2024 | Dec 31, 2023 | Dec 29, 2024 | Dec 31, 2023 | |||||||||||||||||||
| Revenue from services: | |||||||||||||||||||||||
| PeopleReady | $ | 207,687 | $ | 285,185 | $ | 868,549 | $ | 1,096,318 | |||||||||||||||
| PeopleScout | 32,528 | 47,204 | 156,643 | 229,334 | |||||||||||||||||||
| PeopleManagement | 145,738 | 159,782 | 542,201 | 580,591 | |||||||||||||||||||
| Total company | $ | 385,953 | $ | 492,171 | $ | 1,567,393 | $ | 1,906,243 | |||||||||||||||
Segment profit (2): | |||||||||||||||||||||||
| PeopleReady | $ | 7,404 | $ | 7,920 | $ | 5,783 | $ | 26,606 | |||||||||||||||
| PeopleScout | 1,301 | 2,910 | 12,152 | 26,922 | |||||||||||||||||||
| PeopleManagement | 5,695 | 2,781 | 15,119 | 6,963 | |||||||||||||||||||
| Total segment profit | 14,400 | 13,611 | 33,054 | 60,491 | |||||||||||||||||||
| Corporate unallocated expense | (5,501) | (8,462) | (21,887) | (31,507) | |||||||||||||||||||
Total company Adjusted EBITDA (3) | 8,899 | 5,149 | 11,167 | 28,984 | |||||||||||||||||||
| Third-party processing fees for hiring tax credits (4) | (90) | 67 | (240) | (253) | |||||||||||||||||||
| Amortization of software as a service assets (5) | (1,752) | (1,233) | (6,162) | (4,117) | |||||||||||||||||||
| Goodwill and intangible asset impairment charge | — | — | (59,674) | (9,485) | |||||||||||||||||||
| PeopleReady technology upgrade costs (6) | (8,318) | (440) | (8,807) | (1,342) | |||||||||||||||||||
| COVID-19 government subsidies, net | — | — | 9,652 | (525) | |||||||||||||||||||
Executive leadership transition costs | — | (3,296) | — | (5,788) | |||||||||||||||||||
| Other adjustments, net (7) | (2,197) | (1,926) | (9,150) | (5,503) | |||||||||||||||||||
EBITDA (3) | (3,458) | (1,679) | (63,214) | 1,971 | |||||||||||||||||||
| Depreciation and amortization (8) | (6,945) | (6,946) | (29,561) | (25,821) | |||||||||||||||||||
Interest and other income (expense), net | 390 | 1,223 | 4,251 | 3,205 | |||||||||||||||||||
Loss before tax (expense) benefit | (10,013) | (7,402) | (88,524) | (20,645) | |||||||||||||||||||
Income tax (expense) benefit | (1,692) | 4,851 | (37,224) | 6,472 | |||||||||||||||||||
| Net loss | $ | (11,705) | $ | (2,551) | $ | (125,748) | $ | (14,173) | |||||||||||||||
| Non-GAAP measure | Definition | Purpose of adjusted measures | ||||||||||||
Adjusted net income (loss) and Adjusted net income (loss) per diluted share | Net loss and net loss per diluted share, excluding: –gain on divestiture, –amortization of intangibles, –goodwill and intangible asset impairment charge, –PeopleReady technology upgrade costs, –COVID-19 government subsidies, net, –executive leadership transition costs, –other adjustments, net, and –tax effect of the adjustments and deferred tax asset valuation allowance. | –Enhances comparability on a consistent basis and provides investors with useful insight into the underlying trends of the business. –Used by management to assess performance and effectiveness of our business strategies. –Provides a measure, among others, used in the determination of incentive compensation for management. | ||||||||||||
| EBITDA and Adjusted EBITDA | EBITDA excludes from net loss: –income tax expense (benefit), –interest and other (income) expense, net, and –depreciation and amortization. Adjusted EBITDA further excludes: –third-party processing fees for hiring tax credits, –amortization of software as a service assets, –goodwill and intangible asset impairment charge, –PeopleReady technology upgrade costs, –COVID-19 government subsidies, net, –executive leadership transition costs, and –other adjustments, net. | –Enhances comparability on a consistent basis and provides investors with useful insight into the underlying trends of the business. –Used by management to assess performance and effectiveness of our business strategies. –Provides a measure, among others, used in the determination of incentive compensation for management. | ||||||||||||
| Adjusted SG&A expense | Selling, general and administrative expense excluding: –third-party processing fees for hiring tax credits, –amortization of software as a service assets, –PeopleReady technology upgrade costs, –COVID-19 government subsidies, net, –executive leadership transition costs, and –other adjustments, net. | –Enhances comparability on a consistent basis and provides investors with useful insight into the underlying trends of the business. | ||||||||||||
| Q4 2024 | Q4 2023 | 2024 | 2023 | ||||||||||||||||||||
13 weeks ended | 14 weeks ended (1) | 52 weeks ended | 53 weeks ended (1) | ||||||||||||||||||||
| (in thousands, except for per share data) | Dec 29, 2024 | Dec 31, 2023 | Dec 29, 2024 | Dec 31, 2023 | |||||||||||||||||||
| Net loss | $ | (11,705) | $ | (2,551) | $ | (125,748) | $ | (14,173) | |||||||||||||||
Gain on divestiture | — | — | (716) | — | |||||||||||||||||||
| Amortization of intangible assets | 489 | 1,355 | 4,051 | 5,175 | |||||||||||||||||||
| Goodwill and intangible asset impairment charge | — | — | 59,674 | 9,485 | |||||||||||||||||||
| PeopleReady technology upgrade costs (2) | 8,318 | 440 | 8,807 | 1,342 | |||||||||||||||||||
| COVID-19 government subsidies, net | — | — | (9,652) | 525 | |||||||||||||||||||
| Executive leadership transition costs | — | 3,296 | — | 5,788 | |||||||||||||||||||
| Other adjustments, net (3) | 2,197 | 1,926 | 9,150 | 5,503 | |||||||||||||||||||
| Tax effect of adjustments and deferred tax asset valuation allowance (4) | — | (1,824) | 40,540 | (4,920) | |||||||||||||||||||
Adjusted net income (loss) | $ | (701) | $ | 2,642 | $ | (13,894) | $ | 8,725 | |||||||||||||||
Adjusted net income (loss) per diluted share | $ | (0.02) | $ | 0.08 | $ | (0.46) | $ | 0.28 | |||||||||||||||
| Diluted weighted average shares outstanding | 29,561 | 31,450 | 30,177 | 31,590 | |||||||||||||||||||
| Margin / % of revenue: | |||||||||||||||||||||||
Net loss | (3.0)% | (0.5)% | (8.0)% | (0.7)% | |||||||||||||||||||
Adjusted net income (loss) | (0.2)% | 0.5% | (0.9)% | 0.5% | |||||||||||||||||||
| Q4 2024 | Q4 2023 | 2024 | 2023 | ||||||||||||||||||||
13 weeks ended | 14 weeks ended (1) | 52 weeks ended | 53 weeks ended (1) | ||||||||||||||||||||
| (in thousands) | Dec 29, 2024 | Dec 31, 2023 | Dec 29, 2024 | Dec 31, 2023 | |||||||||||||||||||
| Net loss | $ | (11,705) | $ | (2,551) | $ | (125,748) | $ | (14,173) | |||||||||||||||
Income tax expense (benefit) | 1,692 | (4,851) | 37,224 | (6,472) | |||||||||||||||||||
Interest and other (income) expense, net | (390) | (1,223) | (4,251) | (3,205) | |||||||||||||||||||
| Depreciation and amortization (5) | 6,945 | 6,946 | 29,561 | 25,821 | |||||||||||||||||||
| EBITDA | (3,458) | (1,679) | (63,214) | 1,971 | |||||||||||||||||||
| Third-party processing fees for hiring tax credits (6) | 90 | (67) | 240 | 253 | |||||||||||||||||||
| Amortization of software as a service assets (7) | 1,752 | 1,233 | 6,162 | 4,117 | |||||||||||||||||||
| Goodwill and intangible asset impairment charge | — | — | 59,674 | 9,485 | |||||||||||||||||||
| PeopleReady technology upgrade costs (2) | 8,318 | 440 | 8,807 | 1,342 | |||||||||||||||||||
| COVID-19 government subsidies, net | — | — | (9,652) | 525 | |||||||||||||||||||
| Executive leadership transition costs | — | 3,296 | — | 5,788 | |||||||||||||||||||
| Other adjustments, net (3) | 2,197 | 1,926 | 9,150 | 5,503 | |||||||||||||||||||
| Adjusted EBITDA | $ | 8,899 | $ | 5,149 | $ | 11,167 | $ | 28,984 | |||||||||||||||
| Margin / % of revenue: | |||||||||||||||||||||||
Net loss | (3.0)% | (0.5)% | (8.0)% | (0.7)% | |||||||||||||||||||
| Adjusted EBITDA | 2.3% | 1.0% | 0.7% | 1.5% | |||||||||||||||||||
| Q4 2024 | Q4 2023 | 2024 | 2023 | ||||||||||||||||||||
13 weeks ended | 14 weeks ended (1) | 52 weeks ended | 53 weeks ended (1) | ||||||||||||||||||||
| (in thousands) | Dec 29, 2024 | Dec 31, 2023 | Dec 29, 2024 | Dec 31, 2023 | |||||||||||||||||||
| Selling, general and administrative expense | $ | 106,942 | $ | 129,961 | $ | 410,870 | $ | 494,603 | |||||||||||||||
| Third-party processing fees for hiring tax credits (6) | (90) | 67 | (240) | (253) | |||||||||||||||||||
| Amortization of software as a service assets (7) | (1,752) | (1,233) | (6,162) | (4,117) | |||||||||||||||||||
| PeopleReady technology upgrade costs (2) | (8,318) | (440) | (8,807) | (1,342) | |||||||||||||||||||
| COVID-19 government subsidies, net | — | — | 6,759 | (525) | |||||||||||||||||||
| Executive leadership transition costs | — | (3,296) | — | (5,788) | |||||||||||||||||||
| Other adjustments, net (3) | (2,156) | (1,246) | (8,634) | (3,620) | |||||||||||||||||||
| Adjusted SG&A expense | $ | 94,626 | $ | 123,813 | $ | 393,786 | $ | 478,958 | |||||||||||||||
| % of revenue: | |||||||||||||||||||||||
| Selling, general and administrative expense | 27.7% | 26.4% | 26.2% | 25.9% | |||||||||||||||||||
| Adjusted SG&A expense | 24.5% | 25.2% | 25.1% | 25.1% | |||||||||||||||||||